Role of Navayasa Lauha Vati and Katuki Vati along with lifestyle modifications in the management of nonalcoholic fatty liver disease(Yakrita Vikara) associated with obesity.
- Conditions
- Health Condition 1: E713- Disorders of fatty-acid metabolism
- Registration Number
- CTRI/2023/04/051384
- Lead Sponsor
- Institute of teaching and research in ayurveda,Jamnagar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Age group - 25-60 years.Previously diagnosed and newly diagnosed case of NAFLD (fatty liver grade I or II )confirmed by ultrasonography along with obesity (class1or 2) with or without symptoms of NAFLD (abdominal pain, abdominal heaviness, fatigue, nausea, vomiting, constipation, abdominal distension and burning sensation in abdomen). Patients willing to participate in the clinical trial
Age below 25 years and above 60 years.Patients of NAFLD without obesity.Patients having class III obesity.Patients with uncontrolled DM, (RBS >200mg/dl/), stage II HTN (160/100 mm Hg), Overt hypothyroidism (TSH 10Miu/L) in spite of taking medication.Patients suffering from Hepatitis, Cirrhosis of liver, Ascites, Chronic kidney diseases.Patients suffering from AIDS, Tuberculosis and other infectious diseases, Malignancies, Major psychiatric problems or any other serious illnesses.Pregnant, lactating women. Patient on long term medication (Hepatotoxic medication like NSAID, Rifampicin, steroid) Patients consuming Alcohol or other narcotic substance.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of NAFLD.Timepoint: 0 day and after 8 weeks
- Secondary Outcome Measures
Name Time Method To improve quality of life in patients of NAFLD associated with obesity assessed by CLDQ.Timepoint: on 0 day and after 8 weeks.